PMID- 7083159 OWN - NLM STAT- MEDLINE DCOM- 19820814 LR - 20151119 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 42 IP - 7 DP - 1982 Jul TI - Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. PG - 2671-7 AB - The metabolic N-oxidation of the carcinogen 2-aminofluorene was examined in vitro using fortified hepatic microsomes from a variety of species. Rat, dog, human, and pig liver microsomes catalyzed the formation of N-hydroxy-2-aminofluorene (N-OH-AF) from AF at rates of 1.6, 1.0, 1.2, and 3.5 nmol/min/mg protein, respectively. The involvement of both cytochrome P-450 and the flavin-containing monooxygenase was demonstrated with hepatic microsomes and with purified enzymes by using specific enzyme inhibitors. 2-[(2,4-Dichloro-6-phenyl)phenoxy]ethylamine, a potent cytochrome P-450 inhibitor, decreased microsomal N-OH-AF formation by 96, 83, 70, and 46% in the rat, dog, human, and pig, respectively; and further addition of methimazole, a high-affinity flavin-containing monooxygenase substrate, abolished the residual N-hydroxylating activity. Using the purified porcine flavin-containing monooxygenase, metabolic formation of N-OH-AF occurred at a rate of 4.9 nmol/min/nmol flavin adenine nucleotide and was insensitive to 2-[(2,4-dichloro-6-phenyl)phenoxy]ethylamine inhibitor. In addition, purified rat liver cytochrome P-450 (isolated from 5,6-naphthoflavone-induced animals) N-hydroxylated AF (1.1 nmol/min/nmol P-450) and was completely inhibited by 2-[(2,4-dichloro-6-phenyl)-phenoxy]ethylamine, but the reaction was insensitive for methimazole. To determine whether or not the metabolic formation of N-OH-AF could lead directly to covalently bound adduct(s) with DNA under these incubation conditions (30 min, pH 7.5), the binding of synthetic and metabolically formed [3H]-N-OH-AF to added calf thymus DNA and to DNA in isolated rat liver nuclei was investigated. In all cases, the amount of DNA-bound carcinogen accounted for 0.08 to 0.15% of the N-OH-AF present in the incubation mixtures. These data, when compared to the levels of AF bound to hepatic nuclear DNA reported in vivo, suggest that the nonenzymatic reaction of N-OH-AF with nuclear DNA may be sufficient to account for a substantial portion of the observed in vivo binding of this carcinogen. FAU - Frederick, C B AU - Frederick CB FAU - Mays, J B AU - Mays JB FAU - Ziegler, D M AU - Ziegler DM FAU - Guengerich, F P AU - Guengerich FP FAU - Kadlubar, F F AU - Kadlubar FF LA - eng GR - ES 01590/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Carcinogens) RN - 0 (Fluorenes) RN - 3A69OS195N (2-aminofluorene) RN - 61M94X4V24 (N-hydroxy-2-aminofluorene) RN - 9007-49-2 (DNA) RN - 9035-51-2 (Cytochrome P-450 Enzyme System) RN - EC 1.13.- (Oxygenases) RN - EC 1.14.13.8 (dimethylaniline monooxygenase (N-oxide forming)) SB - IM MH - Animals MH - Carcinogens/*metabolism MH - Cattle MH - Cell Nucleus/*metabolism MH - Cytochrome P-450 Enzyme System/*metabolism MH - DNA/*metabolism MH - Dogs MH - Fluorenes/*metabolism MH - Humans MH - Liver/metabolism/ultrastructure MH - Microsomes, Liver/enzymology MH - Oxygenases/*metabolism MH - Rats MH - Rats, Inbred Strains MH - Swine MH - Thymus Gland/ultrastructure EDAT- 1982/07/01 00:00 MHDA- 1982/07/01 00:01 CRDT- 1982/07/01 00:00 PHST- 1982/07/01 00:00 [pubmed] PHST- 1982/07/01 00:01 [medline] PHST- 1982/07/01 00:00 [entrez] PST - ppublish SO - Cancer Res. 1982 Jul;42(7):2671-7.